Sergio Utrilla-Trigo

417 total citations
22 papers, 270 citations indexed

About

Sergio Utrilla-Trigo is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Sergio Utrilla-Trigo has authored 22 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Ecology, Evolution, Behavior and Systematics and 16 papers in Agronomy and Crop Science. Recurrent topics in Sergio Utrilla-Trigo's work include Viral Infections and Vectors (17 papers), Vector-Borne Animal Diseases (17 papers) and Animal Disease Management and Epidemiology (16 papers). Sergio Utrilla-Trigo is often cited by papers focused on Viral Infections and Vectors (17 papers), Vector-Borne Animal Diseases (17 papers) and Animal Disease Management and Epidemiology (16 papers). Sergio Utrilla-Trigo collaborates with scholars based in Spain, United States and United Kingdom. Sergio Utrilla-Trigo's co-authors include Javier Ortego, Eva Calvo-Pinilla, Alejandro Marín-López, Aitor Nogales, Gema Lorenzo, Sandra Moreno, Júlio Benavides, Alejandro Brun, Carlos Gutiérrez-Ortega and Erol Fikrig and has published in prestigious journals such as Journal of Virology, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Sergio Utrilla-Trigo

21 papers receiving 270 citations

Peers

Sergio Utrilla-Trigo
Hye Kyung Chung United States
Sergio Utrilla-Trigo
Citations per year, relative to Sergio Utrilla-Trigo Sergio Utrilla-Trigo (= 1×) peers Hye Kyung Chung

Countries citing papers authored by Sergio Utrilla-Trigo

Since Specialization
Citations

This map shows the geographic impact of Sergio Utrilla-Trigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Utrilla-Trigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Utrilla-Trigo more than expected).

Fields of papers citing papers by Sergio Utrilla-Trigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Utrilla-Trigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Utrilla-Trigo. The network helps show where Sergio Utrilla-Trigo may publish in the future.

Co-authorship network of co-authors of Sergio Utrilla-Trigo

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Utrilla-Trigo. A scholar is included among the top collaborators of Sergio Utrilla-Trigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Utrilla-Trigo. Sergio Utrilla-Trigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utrilla-Trigo, Sergio, et al.. (2025). The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus. Frontiers in Immunology. 16. 1566225–1566225.
2.
Sebastián, Víctor, Matthias Krämer, José Manuel Delgado‐López, et al.. (2025). Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model. ACS Applied Materials & Interfaces. 17(32). 45538–45554. 1 indexed citations
3.
Utrilla-Trigo, Sergio, Alejandro Marín-López, Germán Andrés, et al.. (2024). Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies. Microbiology Spectrum. 12(3). e0249323–e0249323. 2 indexed citations
4.
Utrilla-Trigo, Sergio, et al.. (2024). IFNAR(-/-) Mice Constitute a Suitable Animal Model for Epizootic Hemorrhagic Disease Virus Study and Vaccine Evaluation. International Journal of Biological Sciences. 20(8). 3076–3093. 3 indexed citations
5.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Gema Lorenzo, et al.. (2024). Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus. Frontiers in Immunology. 15. 1440407–1440407. 4 indexed citations
6.
Calvo-Pinilla, Eva, et al.. (2024). Cytokine mRNA Expression Profile in Target Organs of IFNAR (-/-) Mice Infected with African Horse Sickness Virus. International Journal of Molecular Sciences. 25(4). 2065–2065. 2 indexed citations
7.
Utrilla-Trigo, Sergio, et al.. (2024). Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against Epizootic hemorrhagic disease virus in IFNAR(−/−) mice. Journal of Virology. 98(12). e0168724–e0168724. 1 indexed citations
8.
Marín-López, Alejandro, et al.. (2023). Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines. Pathogens. 12(3). 371–371. 8 indexed citations
9.
Utrilla-Trigo, Sergio, et al.. (2023). Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives. Microorganisms. 11(5). 1339–1339. 34 indexed citations
10.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Alejandro Marín-López, et al.. (2022). The combined expression of the nonstructural protein NS1 and the N-terminal half of NS2 (NS21-180) by ChAdOx1 and MVA confers protection against clinical disease in sheep upon bluetongue virus challenge. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 13 indexed citations
11.
Marín-López, Alejandro, et al.. (2022). Recombinant Modified Vaccinia Virus Ankara Development to Express VP2, NS1, and VP7 Proteins of Bluetongue Virus. Methods in molecular biology. 177–193. 3 indexed citations
12.
Nogales, Aitor, et al.. (2021). Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity. Viruses. 13(9). 1760–1760. 15 indexed citations
13.
Calvo-Pinilla, Eva, Alejandro Marín-López, Sandra Moreno, et al.. (2020). A protective bivalent vaccine against Rift Valley fever and bluetongue. npj Vaccines. 5(1). 70–70. 28 indexed citations
14.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Alejandro Marín-López, et al.. (2020). Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines. 8(3). 346–346. 21 indexed citations
15.
Calvo-Pinilla, Eva, et al.. (2020). Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design. Current Opinion in Virology. 44. 49–56. 9 indexed citations
16.
Utrilla-Trigo, Sergio, et al.. (2020). Inhibition of Orbivirus Replication by Aurintricarboxylic Acid. International Journal of Molecular Sciences. 21(19). 7294–7294. 14 indexed citations
17.
Marín-López, Alejandro, Eva Calvo-Pinilla, Sandra Moreno, et al.. (2019). Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor. Viruses. 11(1). 35–35. 27 indexed citations
18.
Marín-López, Alejandro, Sergio Utrilla-Trigo, Diego Barriales, et al.. (2019). Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara. Vaccine. 38(4). 882–889. 12 indexed citations
19.
Utrilla-Trigo, Sergio, et al.. (2017). Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología. 53(5). 251–256. 22 indexed citations
20.
Utrilla-Trigo, Sergio, et al.. (2016). Estudio de 5 compuestos orgánicos volátiles en aire exhalado en la enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología. 53(5). 251–256. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026